Atrial Fibrillation

Atrial fibrillation (AF or Afib) is the most common cardiac arrhythmia affecting millions worldwide.  AF causes the left atrium to fibrillate leading to blood clot formation and increased risk of stroke. 

 

תמונה11.png

20%-30% of all strokes occur in AF patients

תמונה12.png

The lifetime risk of getting AF is 1 in 4

Atrial Fibrillation
Therapy Today

(Catheter Ablation)

 

AF may be treated with medication, cardioversion or with catheter ablation which is considered the golden standard interventional procedure.   In catheter ablation procedures lesions are formed in the left atrium around the pulmonary veins where the irregular electrical signals are coming from.  Lesions are created with catheters that deliver uniform energy via direct contact with the tissue leading to its destruction and therefore, blockage of the irregular electrical.

 

Atrial Fibrillation Therapy Today

The Problem

Existing solutions difficult to use

 

תמונה16.png

Up to 40% of patients require 2nd procedure

 

Atrial Fibrillation Therapy
תמונה9.png
עיגול.png

Tissue contact 
is mandatory

תמונה9.png
עיגול.png

No tissue thickness measurement

תמונה9.png
עיגול.png

No lesion monitoring

The Solution 

No-Contact Guided Ablation

The first product that allows:

תמונה191.png
תמונה191.png
Atrial Fibrillation Therapy Today

Contactless ablation​

Automatic power titration based on tissue thickness​

תמונה191.png

Real-time lesion monitoring